Neoadjuvant chemotherapy of locally advanced breast cancer: Predicting response with in vivo 1H MR spectroscopy - A pilot study at 4 T

Radiology

Volumn 233, Issue 2, 2004, Pages 424-431

  Meisamy, Sina ^a   Bolan, Patrick J ^a   Baker, Eva H ^a   Bliss, Robin L ^a   Gulbahce, Evin ^a   Everson, Lenore I ^a   Nelson, Michael T ^a   Emory, Tim H ^a   Tuttle, Todd M ^a   Yee, Douglas ^a   Garwood, Michael ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Breast neoplasms, MR, 00.12145; Breast neoplasms, therapy, 00.32; Chemotherapy; Magnetic resonance (MR), spectroscopy

Indexed keywords

CHOLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GADOLINIUM;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER INVASION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; EVALUATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; PILOT STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RANK SUM TEST; SOLID TUMOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SYSTEMIC THERAPY; TIME; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NEOADJUVANT THERAPY; PILOT PROJECTS;

EID: 7044228014     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2332031285     Document Type: Article

References (36)

1. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from national surgical adjuvant breast and bowel project B-18. J Clin Oncol 1997; 15:2483-2493.
2. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on outcome of women with operable breast cancer. J Clin Oncol 1998; 16:2672-2685.
3. Smith IC, Heys SD, Hutcheon AW, et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 2002; 20: 1456-1466.
4. Kaufmann M, Von Minckwitz G, Smith R, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 2003; 21:2600-2608.
5. Junkermann H, von Fournier D. Imaging methods for evaluating the response of breast carcinoma to preoperative chemotherapy. Radiologe 1997; 37:726-732.
6. Segel MC, Paulus DD, Hortobagyi GN. Advanced primary breast cancer: assessment at mammography response to induction chemotherapy. Radiology 1988; 169:49-54.
7. Vinnicombe SJ, MacVicar AD, Guy RL, et al. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 1996; 198:333-340.
8. Herrada J, Iyer RB, Atkinson EN, Sneige N, Buzdar AU, Hortobagyi GN. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neo-adjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 1997; 3:1565-1569.
9. Esserman L, Kaplan E, Partridge S, et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 2001; 8:549-559.
10. Gilles R, Guinebretiere JM, Toussaint C, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative neoadjuvant chemotherapy. Radiology 1994; 191:633-638.
11. Abraham DC, Jones RC, Jones SE, et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996; 78:91-100.
12. Balu-Maestro C, Chapellier C, Bluese A, Chanalet I, Chauvel C, Largillier R. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 2002; 72: 145-152.
13. Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kühn T. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002; 12:1711-1719.
14. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003; 17: 509-520.
15. Delille J, Slanetz PJ, Yeh ED, Halpern EF, Kopans DB, Garrido L. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging-pilot study. Radiology 2003; 228:63-69.
16. Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997; 204:661-666.
17. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998; 209:269-275.
18. Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 1999; 19:1737-1746.
19. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo 1H NMR spectra with increased magnetic field strength. J Magn Reson Imaging 1999; 10:159-164.
20. Katz-Brull R, Lavin PT, Lenkinski R. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002; 94:1197-1203.
21. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001; 84:1016-1022.
22. Schwarz AJ, Maisey NR, Collins DJ, Cunningham D, Huddart R, Leach MO. Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours. Br J Radiol 2002; 75:959-966.
23. Lazareff JA, Gupta RK, Alger J. Variation of post-treatment 1H-MRSI choline intensity in pediatric gliomas. J Neurooncol 1999; 41:291-298.
24. Bolan PJ, DelaBarre L, Baker EH, et al. Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med 2002; 48:215-222.
25. Bolan PJ, Meisamy S, Baker EH, et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 2003; 50: 1134-1143.
26. Merkle H, DelaBarre L, Bolan PJ, et al. Transceive quadrature breast coils and applications at 4 Tesla (abstr). In: Proceedings of the Ninth Annual Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2001; 1114.
27. Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001; 153:155-177.
28. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy of rat brain at 1 msec echo time. Magn Reson Med 1999; 41:649-656.
29. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-216.
30. Le CT. Descriptive methods for continuous data: introductory biostatistics. Hoboken, NJ: Wiley, 2003; 85-88.
31. Le CT. Comparison of population means: introductory biostatistics. Hoboken, NJ: Wiley, 2003; 246-281.
32. Henderson IC, Berry DA, Demetri GD, et al. Improved outcomes for adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 2003; 21:976-983.
33. Podo F. Tumour phospholipid metabolism. NMR Biomed 1999; 12:413-439.
34. Degani H, Rushkin E, Eliyahu G. Variations in the augmentation of phosphocholine in breast cancer; the cause and the sense (abstr). In: Proceedings of the 11th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2003; 1280.
35. Vaughan JT, Garwood M, Collins CM, et al. 7T vs 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med 2001; 46:24-30.
36. Hoult DI, Richard RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 1976; 24:71-85.